The results of two landmark studies announced today at the Sixth European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ECCEO), confirms the evidence based, long-term efficacy of Protelos (strontium ranelate) for the reduction of nonvertebral and vertebral osteoporotic fractures over five years. This is the first time an anti-osteoporotic treatment has demonstrated fracture reduction efficacy after five years of treatment.
Recent Blog Post

September, 2023
Study Reveals Higher BMI Puts Adolescents at Risk for Depression
5th September 2023 – By King’s College London Children between the ages of 12 and 16 with a higher body...

August, 2023
Diversity at TwinsUK: Genevieve
Genevieve joined the department in 2010 and has since gained an extensive knowledge of the TwinsUK data. She is responsible...

August, 2023
Diversity at TwinsUK: Bridget
Bridget is one of our Clinical Research Nurses, part of the clinic team who you’ll see when coming to St...